SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-16-437329
Filing Date
2016-01-26
Accepted
2016-01-26 06:08:31
Documents
1
Group Members
DAVID SCHNELL, M.D.PROSPECT MANAGEMENT CO. II, L.L.C.PROSPECT MANAGEMENT CO., L.L.C.PROSPECT VENTURE PARTNERS, L.P.RUSSELL C. HIRSCH, M.D., PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d35510dsc13ga.htm SC 13G/A 123989
  Complete submission text file 0001193125-16-437329.txt   125882
Mailing Address 435 TASSO STREET SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST STE 200 PALO ALTO CA 94301 6503278800
PROSPECT VENTURE PARTNERS II LP (Filed by) CIK: 0001135669 (see all company filings)

IRS No.: 770565416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Subject) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88337 | Film No.: 161359918
SIC: 2834 Pharmaceutical Preparations